Yes they snuck that in right at the end didn't they.
12.5m performance shares when JCT makes revenue threshold of the following:
$3m
$6m
$12m.
As the market continues to realise that XPE is not actually XPE but rather an underperforming small business called JCT Healthcare, share price will be battered!
I know tradesman who's small businesses turn over more than JCT Healthcare and they certainly aren't paying themselves million dollar executive salaries.
Ann: Preliminary Final Report - Appendix 4E, page-6
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
